All Posts By

Smartkarma Daily Briefs

Daily Brief Industrials: Voltas Ltd, Fortive , Intloop , Simpson Manufacturing Co, Inc, Srg Takamiya, On Assignment, Old Dominion Freight Line, Deutsche Post and more

By | Daily Briefs, Industrials

In today’s briefing:

  • India’s Summer Stock: Voltas Ltd- Navigating Supply Headwinds
  • Fortive Corporation: How Its 2025 Spin-Off Could Reshape the Business!
  • Intloop (9556 JP) – Demonstrating Operational Leverage
  • Simpson Manufacturing Co.: These Are The 5 Biggest Hindrances In Its Path For Growth In 2025 & Beyond!
  • Q3 Follow-Up: Takamiya (2445 JP) – March 10, 2025
  • ASGN Inc.: Will The Strategic Acquisition Of TopBloc Be A Game Changer?
  • Old Dominion Freight: Inside the LTL Leader’s Plan to Maintain Its Competitive Edge!
  • Deutsche Post AG – What’s News in Amsterdam


India’s Summer Stock: Voltas Ltd- Navigating Supply Headwinds

By Sudarshan Bhandari

  • Voltas Ltd (VOLT IN) is shifting to a volume-led strategy while investing INR 260 crore to build in-house compressor manufacturing under PLI 3.0.
  • This approach de-risks supply chains, maintains mass-market pricing, and supports growth amid rising raw material and currency pressures.
  • Voltas is evolving from a margin-led to scale-focused player, making it a resilient long-term bet on India’s low AC penetration and summer-driven demand.

Fortive Corporation: How Its 2025 Spin-Off Could Reshape the Business!

By Baptista Research

  • Fortive Corporation recently presented their fourth-quarter and full-year results, highlighting a combination of strengths and challenges that investors might consider when evaluating the company’s investment potential.
  • Positive aspects of Fortive’s performance include a strong track record of financial accomplishments in 2024.
  • The company reported better-than-expected core growth, adjusted earnings, and free cash flow, capping a robust year.

Intloop (9556 JP) – Demonstrating Operational Leverage

By Astris Advisory Japan

  • We believe the key highlight of Q1-2 FY7/25 results is OPM expansion YoY from 4.7% to 6.6%.
  • The company aims to secure high-margin projects aligned with its strategic aims while maintaining business investment in new hires to grow.
  • Business expansion via strategic alliances is bearing fruit with Itochu Corporation (8001), with other initiatives being unveiled in the food and logistics sectors to expand and diversify the solutions portfolio and accelerate growth. 

Simpson Manufacturing Co.: These Are The 5 Biggest Hindrances In Its Path For Growth In 2025 & Beyond!

By Baptista Research

  • Simpson Manufacturing Company reported its financial performance for the fiscal year 2024 amidst challenges in the housing markets in both the U.S. and Europe.
  • The company’s net sales for 2024 reached $2.23 billion, showing modest growth compared to 2023.
  • In North America, net sales increased to $1.74 billion, supported by sales volume enhancements and acquisitions, although the company faced a competitive landscape, with housing starts remaining lower.

Q3 Follow-Up: Takamiya (2445 JP) – March 10, 2025

By Sessa Investment Research

  • Q3 FY2025/3 Earnings results summary: Takamiya (hereafter, the Company) reported its Q3(9M) FY2025/3 consolidated earnings results: sales of JPY 32,335 mn (+0.5% YoY), operating profit of JPY 1,316 mn (-45.3% YoY), ordinary profit of JPY 1,209 mn (-52.1% YoY), and profit attributable to owners of parent (hereafter, net profit) of JPY 867 mn (-49.8% YoY).
  • Due to the postponement of the large-scale projects’ commencements, rental volumes fell short of initial expectations.
  • Additionally, due to delays in the delivery schedule of sales and OPE-MANE projects, the net sales saw only a slight increase.

ASGN Inc.: Will The Strategic Acquisition Of TopBloc Be A Game Changer?

By Baptista Research

  • ASGN Incorporated’s latest earnings report reveals a complex picture of the company’s performance and strategic initiatives for the fourth quarter and full year of 2024.
  • On the positive side, ASGN has shown a robust commitment to advancing its business towards higher-end IT consulting solutions, with IT consulting revenues now forming a notable portion of total revenues, increasing from 53% to 58% year-over-year.
  • This growth highlights the strategic shift toward a more specialized, high-margin service offering, particularly in areas like AI, cybersecurity, and data infrastructure.

Old Dominion Freight: Inside the LTL Leader’s Plan to Maintain Its Competitive Edge!

By Baptista Research

  • Old Dominion Freight Line, a prominent player in the less-than-truckload (LTL) industry, reported its fourth quarter and full-year 2024 financial results amidst a challenging economic environment.
  • The earnings call highlighted both positive and negative aspects, providing a comprehensive view of the company’s current standing and future prospects.
  • On the positive side, Old Dominion Freight Line reported strong operational discipline and superior customer service despite declining revenue.

Deutsche Post AG – What’s News in Amsterdam

By The IDEA!

  • In today’s edition: • Unilever | to sell The Vegetarian Butcher to Vivera • InPost/Allegro/DHL | DS Smith survey illustrates the importance of the last mile delivery • PostNL | Budbee plans to triple its APM footprint in the Netherlands • Dutch consumer confidence | dropped even further in March

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: Hankyu Hanshin REIT, Inc., Korea Stock Exchange KOSPI 200, KE Holdings , Korea Stock Exchange Kospi Index, Manappuram Finance, Spectral AI and more

By | Daily Briefs, Financials

In today’s briefing:

  • Hankyu Hanshin REIT (8977) – Good Fundamental News, a Bigly Buyback, and Cascading Flows to Come
  • Short Selling Resumes in Korea Just as the KOSPI 200 Braces for Pullback (Perfect Timing!)
  • [KE Holdings (BEKE US, BUY, TP US$25) Earnings Review]: Housing Inventory Resolution Drives Recovery
  • Korea’s FSC Just Dropped the Final Playbook on the Full Restart of Short Selling.
  • Manappuram Finance: Bain Capital’s Entry Signals a New Chapter, But Challenges Remain
  • MDAI: Burn Study Topline Data


Hankyu Hanshin REIT (8977) – Good Fundamental News, a Bigly Buyback, and Cascading Flows to Come

By Travis Lundy

  • 3D Investment Partners launched a Partial Tender Offer to buy a 10+% stake in Hankyu Hanshin REIT, Inc. (8977 JP). The REIT finally responded with a “Neutral” stance. 
  • But they also upgraded earnings forecasts, bought a building, and announced the Sponsor would buy units in the market over the next year. It’s big. 
  • And that creates flows, which then engender other reactive flows, and cascading flows, and because the sector isn’t rich, there may be a tailwind.

Short Selling Resumes in Korea Just as the KOSPI 200 Braces for Pullback (Perfect Timing!)

By Nico Rosti

  • Short selling in all stocks in South Korea will resume from 31 March 2025. The KOSPI 200 (KOSPI2 INDEX EQUITY) is approaching the overboughtarea according to our models.
  • If the KOSPI 200 can rise for another week, it would be perfectly ripe for a large, high probability SHORT trade.
  • The probability of WEEKLY reversal in the range between the last Close (355) and the 363 resistance limit is between 50% and 75%, pretty high.

[KE Holdings (BEKE US, BUY, TP US$25) Earnings Review]: Housing Inventory Resolution Drives Recovery

By Eric Wen

  • Beike reported C4Q24 revenue beat our estimate/consensus by 8.4%/7.4%, non-GAAP OP miss our estimate/consensus by 37.5%/21.6%, due to front-loading expansion cost.
  • We expect Beike to take 2-3ppt of market share in a rebalancing property market in 2025. 
  • We keep the stock as BUY and keep TP at US$25.

Korea’s FSC Just Dropped the Final Playbook on the Full Restart of Short Selling.

By Sanghyun Park

  • Today’s update clarifies which brokers are fully linked to NSDS, giving them an edge in short-selling speed and flexibility, while others face more execution constraints.
  • This leads to a clear execution risk gap, requiring traders to factor in trade efficiency differences based on their broker.
  • With lower short-selling restriction triggers, liquidity and short-covering dynamics will shift, requiring traders to reassess market impact and adjust strategies accordingly.

Manappuram Finance: Bain Capital’s Entry Signals a New Chapter, But Challenges Remain

By Nimish Maheshwari

  • Bain Capital is acquiring a 41.7–46% stake in Manappuram Finance (MGFL IN), marking a shift from a promoter-led to a professionally managed NBFC.
  • This deal injects INR 4,385 crore in fresh capital, strengthens governance, and positions Manappuram for growth beyond gold loans into microfinance, vehicle loans, and housing finance.
  • While execution risks remain, Bain’s track record in financial services suggests a long-term transformation, potentially closing Manappuram’s valuation gap with Muthoot Finance.

MDAI: Burn Study Topline Data

By Zacks Small Cap Research

  • Spectral AI is developing an AI-guided predictive medical device that employs multispectral imaging (MSI) to estimate a wound’s capacity to heal.
  • The company is pursuing indications in burn and diabetic foot ulcers (DFUs) with the former receiving support from BARDA & other government agencies.
  • Spectral is distinguished by its combination of MSI and AI to improve diagnoses.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Vcanbio Cell & Gene Engineering, Binex Co Ltd, Edwards Lifesciences, Waters Corp, Sareum Holdings, Bristol Myers Squibb Co and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Quiddity Leaderboard CSI Medical Jun25: Three ADDs/DELs Likely; >2x ADV to Trade for Most Names
  • KOSDAQ150 Index Adhoc Rebalance: Binex (053030 KS) To Replace HLB Life Science (067630 KS)
  • Edwards Lifesciences: Inside the High-Stakes Race for the Next Big Cardiac Breakthrough!
  • Waters Corporation: Regulatory & Application Growth in PFAS Testing Is Critical Growth Enabler!
  • Sareum Holdings — New fund-raise and licence signal active 2025
  • Bristol-Myers Squibb: EMERGENT-4 & Key Elements Of Its Therapeutic Pipeline That Could Shape Its Future!
  • Sareum Holdings PLC – Opportunistic Opportunity 13 March 2025


Quiddity Leaderboard CSI Medical Jun25: Three ADDs/DELs Likely; >2x ADV to Trade for Most Names

By Janaghan Jeyakumar, CFA

  • The CSI Medical Index represents the top 50 largest and most-liquid stocks involved in medical devices, medical care, medical informatization, and other medical themes in China.
  • In this insight, we take a look at the potential ADDs and DELs leading the race for the semiannual index rebal event in June 2025.
  • We expect up to three ADDs and three DELs in June 2025 based on the latest available data (where 90% of the reference period is complete).

KOSDAQ150 Index Adhoc Rebalance: Binex (053030 KS) To Replace HLB Life Science (067630 KS)

By Brian Freitas

  • HLB Life Science (067630 KS) was added to the Investment Attention Issue list on 21 March and traded limit down. Then came the announcement of the KOSDAQ 150 Index deletion.
  • As the highest ranked non-constituent from the Healthcare sector at the December rebalance, Binex (053030 KS) will be added to the KOSDAQ 150 Index at the close on 25 March.
  • Historically, intra-review inclusions have moved higher between announcement and implementation and there has been reversion post the index inclusion.

Edwards Lifesciences: Inside the High-Stakes Race for the Next Big Cardiac Breakthrough!

By Baptista Research

  • Edwards Lifesciences Corporation recently reported its financial results for the fourth quarter and the full year of 2024, providing an insight into its strategic performance and outlook.
  • The company, solely focused on structural heart solutions after divesting its Critical Care segment in the third quarter of 2024, recorded robust financial performance, consistent with its expectations and strategic focus.
  • For the full year 2024, Edwards Lifesciences reported a 9% increase in sales, reaching $5.4 billion.

Waters Corporation: Regulatory & Application Growth in PFAS Testing Is Critical Growth Enabler!

By Baptista Research

  • Waters Corporation reported strong fourth quarter and full-year financial results for 2024, reflecting a positive growth trajectory within the life sciences sector.
  • The company achieved a 6.4% reported sales growth in the fourth quarter, 8% on a constant currency basis, and attained high single-digit growth in instruments and recurring revenues.
  • Earnings per share (EPS) showcased robust growth with a 13% increase to $4.10 on a non GAAP basis, showcasing the firm’s resilience amidst challenging economic conditions.

Sareum Holdings — New fund-raise and licence signal active 2025

By Edison Investment Research

Sareum Holdings has announced the acquisition of the licence for SRA737, a checkpoint kinase 1 (CHK1) inhibitor, in which the company had previously held a 27.5% economic interest. Following this acquisition, Sareum will be eligible for 63.5% of all future returns from the programme. SRA737 is a clinical-stage asset, having completed two Phase I/II trials with encouraging headline data, and we believe that this deal will provide Sareum with greater control over its development pathway and future plans. The company has also announced an equity raise for gross proceeds of £1.07m, against an issue of 8.56m shares, to an institutional investor. We expect this to provide greater flexibility to Sareum as it advances its pipeline, in particular lead asset SDC-1801, which is approaching Phase II studies, in autoimmune disorders.


Bristol-Myers Squibb: EMERGENT-4 & Key Elements Of Its Therapeutic Pipeline That Could Shape Its Future!

By Baptista Research

  • Bristol-Myers Squibb’s (BMS) fourth quarter 2024 earnings call reveals a mixed outlook for the company.
  • Positively, there were strong performances in certain areas of the company, reflecting a solid execution of its growth strategy.
  • The growth portfolio delivered a double-digit increase, driven by key brands like Breyanzi, Camzyos, Reblozyl, and Opdualag.

Sareum Holdings PLC – Opportunistic Opportunity 13 March 2025

By Hybridan

  • The licence for SRA737 became available following the programme’s return from a US-based biopharma company.
  • As from December 2024, the licence reverted to the CRT Pioneer Fund (CPF).
  • Sareum has now acquired this licence, and the economic terms have been renegotiated, so Sareum will receive a net 63.5% of all future revenues, up from 27.5%.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Deckers Outdoor, Mayora Indah, Cie Automotive Sa, Games Workshop Group PLC, Hershey Co/The, Nexteq , Botswana Diamonds, TSE Tokyo Price Index TOPIX, Carnival Corp, Celsius Holdings and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Deckers Outdoor: Ugg’s Profit Machine and Hoka’s Expansion—What Investors Need to Know!
  • Mayora (MYOR): Indo Sugar Tax – A Negative
  • CIE’s Partial Takeover Offer Puts Shareholders in the Fast Lane
  • Games Workshop Group — Fifth dividend of FY25 declared
  • The Hershey Co: Can Pricing Power and Innovation Keep Profits Sweet?
  • Nexteq PLC – Friday Take Away: 14 March 2025
  • Hybridan Small Cap Feast: 13/03/2025
  • “TSE’s Request” Catalyzes and Attracts Activist Investors to Invest
  • Carnival Corporation: Will These 3 Key Forces Make or Break Its Market Position by 2028?
  • Celsius Holdings: How Are They Aligning Towards The Broader Market Trend Of Health-Oriented Beverages?


Deckers Outdoor: Ugg’s Profit Machine and Hoka’s Expansion—What Investors Need to Know!

By Baptista Research

  • Deckers Brands delivered a robust performance in its third quarter of fiscal 2025, signaling both high levels of growth and notable profitability.
  • The company’s revenue increased by 17% compared to the previous year, reaching $1.83 billion, with significant contributions from the UGG and HOKA brands.
  • The gross margins improved to 60.3%, and diluted earnings per share rose by 19% to $3.

Mayora (MYOR): Indo Sugar Tax – A Negative

By Henry Soediarko

  • The sugar tax in Indonesia is plan to be introduced July this year, around Rp 1500/liter for sweetened packaged drinks including soft drinks, bottled tea.
  • Mayora Indah (MYOR IJ) tea product is Teh Pucuk Harum, that is widely sold in hypermarts and convenience stores, while Unilever Indonesia (UNVR IJ) no longer owns Teh Sosro. 
  • Expecting sentiment to be better, Short Mayora and Long Unilever. 

CIE’s Partial Takeover Offer Puts Shareholders in the Fast Lane

By Jesus Rodriguez Aguilar

  • CIE Automotive launches a 10%partial takeover offer at €24.00, offering a 7% premium to recent trading levels, taking advantage of recent share price weakness.
  • Valuation suggests shares are undervalued; DCF and peer comps support a fair value of €31–33.
  • Offer aims to boost liquidity, with potential future placements to improve free float and attract institutional investors.

Games Workshop Group — Fifth dividend of FY25 declared

By Edison Investment Research

Games Workshop Group (GAW) has declared its fifth dividend of FY25. We believe this reflects enhanced cash generation as a result of the success of the video game Space Marine 2, which has passed through its minimum guarantee income, on top of the strong growth provided by the FY25 launch of the latest edition of Age of Sigmar. GAW’s strong free cash flow growth in FY25 is evidenced by the relative step-up in the dividend versus profit growth from FY24 and when comparing the changes for profit and dividend in FY24 from FY23. We make no changes to our estimates beyond increasing the FY25 dividend to £5.20/share.


The Hershey Co: Can Pricing Power and Innovation Keep Profits Sweet?

By Baptista Research

  • The Hershey Company recently reported its fourth-quarter 2024 earnings, revealing various elements influencing its financial performance and outlook.
  • The company addressed challenges such as elevated cocoa prices, sustaining growth despite market pressures, and strategically managing its product line.
  • Hershey has been proactive in handling cocoa price volatility through hedging, allowing it to avoid paying market prices immediately.

Nexteq PLC – Friday Take Away: 14 March 2025

By Hybridan

  • Friday Takeaway—delving a little deeper into UK small caps Friday Takeaway from UK Small Caps This will delve a little deeper on individual companies and focus on non-house stocks under £200m market capitalisation to raise awareness 14th March 2025 Alphabetically arranged Share prices and market capitalisations taken from Alpha Terminal from the current price on the day of publication.
  • Top three shareholders are taken from the websites of the companies that we are writing about, unless there is a more up to date TR-1 notification RNS announcement.
  • Disruptive changes could generate opportunities for these two companies ABDX Flowing Downhill NXQ Follow the Money Abingdon Health 6.75p £12.32m (ABDX) Financial Calendar: Year End June, Report October, Interims December, Report April Three Main Shareholders: Octopus Investments Limited 10.1%, Cannacord Genuity Group Inc 9.7% Mercia 9.3% Key Investment Points: Fund Raise, Acquisition, US office Opened, Growth should follow Interims to December 2024 are due to be reported by this lateral flow test contract research (CRO) and contract development and manufacturing organisation (CDMO).

Hybridan Small Cap Feast: 13/03/2025

By Hybridan

  • Botswana Diamonds 0.105p £1.3m (BOD.L) The diamond exploration Company recently announced securing Polymetallic Acreage following a comprehensive artificial intelligence driven exploration programme in Botswana.
  • Eleven prospecting licences were applied for to secure the key polymetallic targets identified, with the licenses including Copper, Silver, Cobalt, Gold, Nickel, Zinc and PGM targets.
  • The initial focus was on diamonds, however, this has been expanded to look for hidden polymetallic deposits. 

“TSE’s Request” Catalyzes and Attracts Activist Investors to Invest

By Aki Matsumoto

  • When investing in a larger company, one can expect higher liquidity, higher expectations of endorsement of the activist investor’s views because of the large institutional holdings, and smoother communication.
  • As cross-shareholding structures are beginning to break down, there’re many opportunities for activist investors to attack such companies because they couldn’t create value and grow due to underutilization of resources.
  • Activist investors have invested in Japanese companies in the past, but never with such success. This success is largely due to a change in the environment.

Carnival Corporation: Will These 3 Key Forces Make or Break Its Market Position by 2028?

By Baptista Research

  • Carnival Corporation & plc recently reported strong results for the fourth quarter of 2024, closing an exceptional year marked by solid financial performance.
  • The company achieved record revenues and customer deposits, with net income improving significantly year-over-year.
  • This performance was driven by robust demand, reflecting a continuation of the momentum observed over the past two years.

Celsius Holdings: How Are They Aligning Towards The Broader Market Trend Of Health-Oriented Beverages?

By Baptista Research

  • Celsius Holdings, Inc. recently shared its fourth-quarter and full-year financial results for 2024, along with the announcement of its acquisition of Alani Nu, a significant player in the U.S. energy drink category.
  • The company’s fiscal performance indicates a robust revenue of $1.36 billion for the year, marking a 3% increase from the previous year, despite facing challenges that have affected many consumer packaged goods sectors.
  • Key positives from the report include a solid 22% year-over-year volume growth, outstripping the overall energy drink category’s growth of 5%.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: CoreWeave, Deckers Outdoor, Fortive , Epam Systems, Alphabet , Crude Oil, Edwards Lifesciences, Autodesk Inc, Enterprise Products Partners, Bristol Myers Squibb Co and more

By | Daily Briefs, United States

In today’s briefing:

  • CoreWeave Inc. (CRWV): IPO Valuation Is Fair for AI Industry Believers
  • Deckers Outdoor: Ugg’s Profit Machine and Hoka’s Expansion—What Investors Need to Know!
  • Fortive Corporation: How Its 2025 Spin-Off Could Reshape the Business!
  • EPAM Systems: AI, Cloud & Expansion—Is This the Next IT Powerhouse?
  • Alphabet’s $32 Billion Bet On Wiz: A Desperate Move or a Strategic Masterstroke?
  • [ETP 2025/12] WTI Gains on Geopolitical Uncertainty, Henry Hub Falls on Rising Nat-Gas Stockpiles
  • Edwards Lifesciences: Inside the High-Stakes Race for the Next Big Cardiac Breakthrough!
  • Autodesk Under Seige: Activist Starboard’s Proxy Battle & What It Means for Shareholders!
  • Enterprise Product Partners: How Is It Dealing With Export Market Volatility & Other Challenge?
  • Bristol-Myers Squibb: EMERGENT-4 & Key Elements Of Its Therapeutic Pipeline That Could Shape Its Future!


CoreWeave Inc. (CRWV): IPO Valuation Is Fair for AI Industry Believers

By IPO Boutique

  • The valuation of the company in our opinion is “fair” and not “stretching the limit” for investors who believe in AI industry trends.
  • A channel check of this offering revealed that the deal is considered well-oversubscribed with early 1-on-1 conversions and a strong shadow book. 
  • The company is a growth story through and through. They have grown from $16m in revenue in 2022 to $1.9bn in 2024 – the year-over-year growth in 2024 was 737%.

Deckers Outdoor: Ugg’s Profit Machine and Hoka’s Expansion—What Investors Need to Know!

By Baptista Research

  • Deckers Brands delivered a robust performance in its third quarter of fiscal 2025, signaling both high levels of growth and notable profitability.
  • The company’s revenue increased by 17% compared to the previous year, reaching $1.83 billion, with significant contributions from the UGG and HOKA brands.
  • The gross margins improved to 60.3%, and diluted earnings per share rose by 19% to $3.

Fortive Corporation: How Its 2025 Spin-Off Could Reshape the Business!

By Baptista Research

  • Fortive Corporation recently presented their fourth-quarter and full-year results, highlighting a combination of strengths and challenges that investors might consider when evaluating the company’s investment potential.
  • Positive aspects of Fortive’s performance include a strong track record of financial accomplishments in 2024.
  • The company reported better-than-expected core growth, adjusted earnings, and free cash flow, capping a robust year.

EPAM Systems: AI, Cloud & Expansion—Is This the Next IT Powerhouse?

By Baptista Research

  • EPAM Systems Inc. reported its fourth quarter and full-year 2024 performance showing mixed results, noting both achievements and challenges.
  • During the fourth quarter, the company experienced revenue growth of 7.9% on a reported basis, including the effects of recent acquisitions, NEORIS and First Derivative.
  • On an organic constant currency basis, revenue grew a modest 1% year-over-year, marking a return to organic growth for the first time since early 2023.

Alphabet’s $32 Billion Bet On Wiz: A Desperate Move or a Strategic Masterstroke?

By Baptista Research

  • Alphabet Inc., Google’s parent company, has officially announced its largest acquisition to date, agreeing to purchase cybersecurity startup Wiz for $32 billion in cash.
  • The move comes after Wiz rejected a $23 billion offer from Alphabet last year, opting instead to explore an IPO.
  • However, with the regulatory landscape shifting under U.S. President Donald Trump’s administration, Wiz’s leadership reconsidered the deal, ultimately securing an extra $9 billion from Google in less than a year.

[ETP 2025/12] WTI Gains on Geopolitical Uncertainty, Henry Hub Falls on Rising Nat-Gas Stockpiles

By Suhas Reddy

  • For the week ending 14/Mar, U.S. crude inventories rose 1.7m barrels (vs. expectations of 0.8m build), gasoline stockpiles fell below expectations, and distillate inventories declined more than anticipated.
  • US natural gas inventories rose by 9 Bcf for the week ending 14/Mar, more than analyst expectations of a 3 Bcf build. Inventories are 10% below the 5-year seasonal average.
  • Barclays cut Exxon’s price target to USD 135 from USD 137 with an Overweight rating, while Citigroup lowered Occidental’s target to USD 51 from USD 56 with a Neutral rating.

Edwards Lifesciences: Inside the High-Stakes Race for the Next Big Cardiac Breakthrough!

By Baptista Research

  • Edwards Lifesciences Corporation recently reported its financial results for the fourth quarter and the full year of 2024, providing an insight into its strategic performance and outlook.
  • The company, solely focused on structural heart solutions after divesting its Critical Care segment in the third quarter of 2024, recorded robust financial performance, consistent with its expectations and strategic focus.
  • For the full year 2024, Edwards Lifesciences reported a 9% increase in sales, reaching $5.4 billion.

Autodesk Under Seige: Activist Starboard’s Proxy Battle & What It Means for Shareholders!

By Baptista Research

  • Autodesk Inc. is at the center of a high-stakes battle as activist hedge fund Starboard Value LP moves forward with a proxy fight, citing financial underperformance and management credibility concerns.
  • After months of behind-the-scenes pressure, Starboard has decided to nominate a minority slate of directors to Autodesk’s board, setting the stage for a potential leadership shake-up.
  • The move comes after a series of turbulent events at Autodesk, including an accounting investigation that led to a CFO replacement, a shift in the company’s sales model, and a recent decision to cut 9% of its workforce.

Enterprise Product Partners: How Is It Dealing With Export Market Volatility & Other Challenge?

By Baptista Research

  • Enterprise Products Partners LP reported its financial results for the fourth quarter of 2024, demonstrating both strengths and challenges within its extensive energy infrastructure network.
  • In terms of financial performance, the company experienced a notable increase in adjusted cash flow from operations, which rose by 4% to $2.3 billion compared to the same quarter the previous year.
  • Net income attributable to common unitholders also increased, registering a 3% rise to $1.6 billion or $0.74 per common unit.

Bristol-Myers Squibb: EMERGENT-4 & Key Elements Of Its Therapeutic Pipeline That Could Shape Its Future!

By Baptista Research

  • Bristol-Myers Squibb’s (BMS) fourth quarter 2024 earnings call reveals a mixed outlook for the company.
  • Positively, there were strong performances in certain areas of the company, reflecting a solid execution of its growth strategy.
  • The growth portfolio delivered a double-digit increase, driven by key brands like Breyanzi, Camzyos, Reblozyl, and Opdualag.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Indonesia: Mayora Indah and more

By | Daily Briefs, Indonesia

In today’s briefing:

  • Mayora (MYOR): Indo Sugar Tax – A Negative


Mayora (MYOR): Indo Sugar Tax – A Negative

By Henry Soediarko

  • The sugar tax in Indonesia is plan to be introduced July this year, around Rp 1500/liter for sweetened packaged drinks including soft drinks, bottled tea.
  • Mayora Indah (MYOR IJ) tea product is Teh Pucuk Harum, that is widely sold in hypermarts and convenience stores, while Unilever Indonesia (UNVR IJ) no longer owns Teh Sosro. 
  • Expecting sentiment to be better, Short Mayora and Long Unilever. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Voltas Ltd, Manappuram Finance, Greenko Energy Holdings and more

By | Daily Briefs, India

In today’s briefing:

  • India’s Summer Stock: Voltas Ltd- Navigating Supply Headwinds
  • Manappuram Finance: Bain Capital’s Entry Signals a New Chapter, But Challenges Remain
  • Lucror Analytics – Morning Views Asia


India’s Summer Stock: Voltas Ltd- Navigating Supply Headwinds

By Sudarshan Bhandari

  • Voltas Ltd (VOLT IN) is shifting to a volume-led strategy while investing INR 260 crore to build in-house compressor manufacturing under PLI 3.0.
  • This approach de-risks supply chains, maintains mass-market pricing, and supports growth amid rising raw material and currency pressures.
  • Voltas is evolving from a margin-led to scale-focused player, making it a resilient long-term bet on India’s low AC penetration and summer-driven demand.

Manappuram Finance: Bain Capital’s Entry Signals a New Chapter, But Challenges Remain

By Nimish Maheshwari

  • Bain Capital is acquiring a 41.7–46% stake in Manappuram Finance (MGFL IN), marking a shift from a promoter-led to a professionally managed NBFC.
  • This deal injects INR 4,385 crore in fresh capital, strengthens governance, and positions Manappuram for growth beyond gold loans into microfinance, vehicle loans, and housing finance.
  • While execution risks remain, Bain’s track record in financial services suggests a long-term transformation, potentially closing Manappuram’s valuation gap with Muthoot Finance.

Lucror Analytics – Morning Views Asia

By Tanvi Arora

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Greenko Energy
  • In the US, the Conference Board Leading Index declined 0.3% (-0.2% e / -0.2% revised p) in February to 101.1. Justyna Zabinska-La Monica, senior manager of business cycle indicators at The Conference Board, noted that “consumers’ expectations of future business conditions turned more pessimistic. Manufacturing new orders, which improved in January, retreated and were the second largest negative contributor to the Index’s monthly decline”.
  • Separately, existing home sales unexpectedly rebounded 4.2% m-o-m (-3.2% e / -4.7% p) to 4.26 mn units in February. Sales climbed the most in the west and south regions, which were afflicted at the start of the year by wildfires in Los Angeles and severe winter storms, respectively.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: Korea Stock Exchange KOSPI 200, Korea Stock Exchange Kospi Index, Binex Co Ltd and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Short Selling Resumes in Korea Just as the KOSPI 200 Braces for Pullback (Perfect Timing!)
  • Korea’s FSC Just Dropped the Final Playbook on the Full Restart of Short Selling.
  • KOSDAQ150 Index Adhoc Rebalance: Binex (053030 KS) To Replace HLB Life Science (067630 KS)


Short Selling Resumes in Korea Just as the KOSPI 200 Braces for Pullback (Perfect Timing!)

By Nico Rosti

  • Short selling in all stocks in South Korea will resume from 31 March 2025. The KOSPI 200 (KOSPI2 INDEX EQUITY) is approaching the overboughtarea according to our models.
  • If the KOSPI 200 can rise for another week, it would be perfectly ripe for a large, high probability SHORT trade.
  • The probability of WEEKLY reversal in the range between the last Close (355) and the 363 resistance limit is between 50% and 75%, pretty high.

Korea’s FSC Just Dropped the Final Playbook on the Full Restart of Short Selling.

By Sanghyun Park

  • Today’s update clarifies which brokers are fully linked to NSDS, giving them an edge in short-selling speed and flexibility, while others face more execution constraints.
  • This leads to a clear execution risk gap, requiring traders to factor in trade efficiency differences based on their broker.
  • With lower short-selling restriction triggers, liquidity and short-covering dynamics will shift, requiring traders to reassess market impact and adjust strategies accordingly.

KOSDAQ150 Index Adhoc Rebalance: Binex (053030 KS) To Replace HLB Life Science (067630 KS)

By Brian Freitas

  • HLB Life Science (067630 KS) was added to the Investment Attention Issue list on 21 March and traded limit down. Then came the announcement of the KOSDAQ 150 Index deletion.
  • As the highest ranked non-constituent from the Healthcare sector at the December rebalance, Binex (053030 KS) will be added to the KOSDAQ 150 Index at the close on 25 March.
  • Historically, intra-review inclusions have moved higher between announcement and implementation and there has been reversion post the index inclusion.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Vcanbio Cell & Gene Engineering, KE Holdings and more

By | China, Daily Briefs

In today’s briefing:

  • Quiddity Leaderboard CSI Medical Jun25: Three ADDs/DELs Likely; >2x ADV to Trade for Most Names
  • [KE Holdings (BEKE US, BUY, TP US$25) Earnings Review]: Housing Inventory Resolution Drives Recovery


Quiddity Leaderboard CSI Medical Jun25: Three ADDs/DELs Likely; >2x ADV to Trade for Most Names

By Janaghan Jeyakumar, CFA

  • The CSI Medical Index represents the top 50 largest and most-liquid stocks involved in medical devices, medical care, medical informatization, and other medical themes in China.
  • In this insight, we take a look at the potential ADDs and DELs leading the race for the semiannual index rebal event in June 2025.
  • We expect up to three ADDs and three DELs in June 2025 based on the latest available data (where 90% of the reference period is complete).

[KE Holdings (BEKE US, BUY, TP US$25) Earnings Review]: Housing Inventory Resolution Drives Recovery

By Eric Wen

  • Beike reported C4Q24 revenue beat our estimate/consensus by 8.4%/7.4%, non-GAAP OP miss our estimate/consensus by 37.5%/21.6%, due to front-loading expansion cost.
  • We expect Beike to take 2-3ppt of market share in a rebalancing property market in 2025. 
  • We keep the stock as BUY and keep TP at US$25.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Japan: Hankyu Hanshin REIT, Inc., Intloop , Japan System Techniques Co, Srg Takamiya, TSE Tokyo Price Index TOPIX and more

By | Daily Briefs, Japan

In today’s briefing:

  • Hankyu Hanshin REIT (8977) – Good Fundamental News, a Bigly Buyback, and Cascading Flows to Come
  • Intloop (9556 JP) – Demonstrating Operational Leverage
  • Q3 Follow-Up: Japan System Techniques (4323 JP) – March 11, 2025
  • Q3 Follow-Up: Takamiya (2445 JP) – March 10, 2025
  • “TSE’s Request” Catalyzes and Attracts Activist Investors to Invest


Hankyu Hanshin REIT (8977) – Good Fundamental News, a Bigly Buyback, and Cascading Flows to Come

By Travis Lundy

  • 3D Investment Partners launched a Partial Tender Offer to buy a 10+% stake in Hankyu Hanshin REIT, Inc. (8977 JP). The REIT finally responded with a “Neutral” stance. 
  • But they also upgraded earnings forecasts, bought a building, and announced the Sponsor would buy units in the market over the next year. It’s big. 
  • And that creates flows, which then engender other reactive flows, and cascading flows, and because the sector isn’t rich, there may be a tailwind.

Intloop (9556 JP) – Demonstrating Operational Leverage

By Astris Advisory Japan

  • We believe the key highlight of Q1-2 FY7/25 results is OPM expansion YoY from 4.7% to 6.6%.
  • The company aims to secure high-margin projects aligned with its strategic aims while maintaining business investment in new hires to grow.
  • Business expansion via strategic alliances is bearing fruit with Itochu Corporation (8001), with other initiatives being unveiled in the food and logistics sectors to expand and diversify the solutions portfolio and accelerate growth. 

Q3 Follow-Up: Japan System Techniques (4323 JP) – March 11, 2025

By Sessa Investment Research

  • Japan System Techniques (hereafter, the Company) announced its Q3(9M)
  • Key consolidated figures net sales of JPY 20,549 mn (+10.9% YoY), operating profit of JPY 2,041 mn (+26.5% YoY), ordinary profit of JPY 2,116 mn (+28.4% YoY), and profit attributable to owners of parent (hereafter, net profit) of JPY 1,417 mn (+28.9% YoY).
  • Higher sales and profits in the DX&SI business and Package business contributed in Q3 earnings growth.

Q3 Follow-Up: Takamiya (2445 JP) – March 10, 2025

By Sessa Investment Research

  • Q3 FY2025/3 Earnings results summary: Takamiya (hereafter, the Company) reported its Q3(9M) FY2025/3 consolidated earnings results: sales of JPY 32,335 mn (+0.5% YoY), operating profit of JPY 1,316 mn (-45.3% YoY), ordinary profit of JPY 1,209 mn (-52.1% YoY), and profit attributable to owners of parent (hereafter, net profit) of JPY 867 mn (-49.8% YoY).
  • Due to the postponement of the large-scale projects’ commencements, rental volumes fell short of initial expectations.
  • Additionally, due to delays in the delivery schedule of sales and OPE-MANE projects, the net sales saw only a slight increase.

“TSE’s Request” Catalyzes and Attracts Activist Investors to Invest

By Aki Matsumoto

  • When investing in a larger company, one can expect higher liquidity, higher expectations of endorsement of the activist investor’s views because of the large institutional holdings, and smoother communication.
  • As cross-shareholding structures are beginning to break down, there’re many opportunities for activist investors to attack such companies because they couldn’t create value and grow due to underutilization of resources.
  • Activist investors have invested in Japanese companies in the past, but never with such success. This success is largely due to a change in the environment.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars